4-methylaminorex

4-Methylaminorex (4-MAR, U4Euh, Ice, Eve) is a stimulant drug of the 2-amino-5-aryloxazoline class that was first synthesized in 1960 by McNeil Laboratories. It is also known as a nootropic due to its cognitive enhancing effects.

Chemistry

4-Methylaminorex has a stereochemistry similar to methamphetamine and is related to ephedrine. It is a member of the 2-amino-5-aryloxazoline class of stimulants. The synthesis of 4-Methylaminorex requires a number of chemicals and laboratory equipment, and is considered moderately difficult to perform.

Pharmacology

4-Methylaminorex acts as a potent and selective agonist at the norepinephrine and dopamine receptors, with little effect on the serotonin receptors. This results in increased levels of these neurotransmitters in the brain, leading to increased alertness, focus, and euphoria.

Effects

The effects of 4-Methylaminorex are similar to those of other stimulants, and include increased energy, focus, and euphoria. However, it also has a number of side effects, including insomnia, anxiety, and potential for addiction.

Legal Status

4-Methylaminorex is a Schedule I controlled substance in the United States, and is also controlled in many other countries. This means that it is illegal to manufacture, distribute, or possess without a license.

See Also

• Amphetamine
• Methamphetamine
• Ephedrine
• 2-amino-5-aryloxazoline

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian